Walgreens Boots Alliance Guides FY24 Adj. EPS Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Walgreens Boots Alliance, Inc. (WBA) initiated its adjusted earnings and sales guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $3.20 to $3.50 per share on revenues between $141.0 billion and $145.0 billion.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $3.73 per share on revenues of $144.36 billion for the year. Analysts' estimates typically exclude special items.
The company said it is not providing guidance beyond fiscal 2024 as it is continuing to evaluate macroeconomic trends and challenges, and expecting to provide long-term guidance, if any, in the future.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Walgreens To Close 1,200 US Stores
Walgreens announced its plan to close around 1,200 U.S stores over the next three years, including around 500 closures in fiscal 2025, as the drug store chain is facing a challenging U.S. retail environment amid increasing competition. The move, which was announced while reporting a significantly wider net loss in its fourth quarter, is expected to be immediately accretive to adjusted earnings...
RTTNews
|
il y a 11h 44min
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March
Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews
|
il y a 226
Verrica Pharmaceuticals Announces Agreement With Walgreens To Distribute YCANTH
Dermatology therapeutics company Verrica Pharmaceuticals Inc. (VRCA) announced Wednesday the expansion of its distribution network by entering into an agreement with Walgreen Co., a subsidiary of Walgreens Boots Alliance, Inc. (WBA), to distribute YCANTH through its specialty pharmacy.
RTTNews
|
il y a 287
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products
The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews
|
il y a 399
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery
Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians. The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.
RTTNews
|
il y a 400
Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update
While reporting financial results for the third quarter on Tuesday, Walgreens Boots Alliance, Inc. (WBA) slashed its adjusted earnings guidance for the full-year 2023 to a range of $4.00 to $4.05 per share from the prior forecast range of $4.45 to $4.65 per share, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.
RTTNews
|
il y a 477
Walgreens, DoorDash, Uber Partner To Launch Free, Same Day Rx Delivery Of HIV Medications
Walgreens Boots Alliance, Inc. (WAG), in partnership with DoorDash, Inc. (DASH) and Uber Technologies, Inc. (UBER), announced Thursday free, Same Day Rx Delivery of medications for the prevention and treatment of HIV.
RTTNews
|
il y a 594
Walgreens, CVS Reportedly Plan To Offer Abortion Pills
Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. are planning to offer abortion pills after the U.S. Food and Drug Administration decided to allow retail pharmacies to sell the product in the United States, reports said. On Tuesday, the agency announced a regulatory change allowing mifepristone, which is used in first-trimester abortions, to be dispensed by retail pharmacies.
RTTNews
|
il y a 650
